What is Arvinas's R&D?

Arvinas (ARVN) reported R&D of $60.3M in Q1 2026.

How has Arvinas's R&D changed year-over-year?

Arvinas's R&D decreased by 33.6% year-over-year, from $90.8M to $60.3M.

What is the long-term trend for Arvinas's R&D?

Over 4 years (2021 to 2025), Arvinas's R&D has grown at a 12.1% compound annual growth rate (CAGR), from $180.4M to $285.2M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Arvinas ARVN R&D

R&D at other companies

Nurix Therapeutics, Inc.NRIX

$84.14M+20.8%

Kymera TherapeuticsKYMR

$98.16M+22.3%

Monte Rosa Therapeutics, Inc.GLUE

$44.07M+36.9%

Relmada Therapeutics, Inc.RLMD

$8.09M-32.3%

Nuvectis Pharma, Inc.NVCT

$4.11M+11.6%

ArriVent BioPharma, Inc.AVBP

$37.62M-38.6%

Segments

By segment

See full

Reportable Segment$60.3M-33.6%

Other financials

Income statement

See full

Revenue$15.6M-91.7%

Operating income-$63.8M-189%

Net income-$57.6M-169%

EPS (diluted)-$0.90-179%

Balance sheet

See full

Cash & equivalents$87.3M+7.8%

Total debt$8.6M-19.6%

Total equity$386.8M-41.4%

Total assets$647.5M-35.3%

Cash flow

See full

Operating cash flow-$69.2M+22.2%

CapEx$1.3M+225%

Free cash flow-$70.5M+21.1%

Valuation

See full

Market cap$518.11M-4.6%

Enterprise value$439.41M-7.1%

P/S5.8×+4.5×

Profitability

See full

Operating margin-283.8%-310pp

Net margin-247.5%-260pp

FCF margin-287.4%—

Returns & leverage

See full

Return on equity-42.3%-53.5pp

Debt / equity0×0.0×

Current ratio5.4×+0.9×

Where this comes from

Reported directly by Arvinas in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Arvinas’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arvinas's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Arvinas's R&D?: Arvinas (ARVN) reported R&D of $60.3M in Q1 2026.
How has Arvinas's R&D changed year-over-year?: Arvinas's R&D decreased by 33.6% year-over-year, from $90.8M to $60.3M.
What is the long-term trend for Arvinas's R&D?: Over 4 years (2021 to 2025), Arvinas's R&D has grown at a 12.1% compound annual growth rate (CAGR), from $180.4M to $285.2M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.